Interestingly, of the six patients in our cohort with anti-synthetase autoantibodies, four had evidence of ILD, suggesting that they confer a greater risk of developing ILD than anti-MDA5, although the incidence in those with anti-Jo-1 autoantibodies (three patients) was similar (33%). This evidence concerns the gene IFIH1 and interstitial lung disease.